Literature DB >> 33494706

Identification of risk factors for in-hospital death of COVID - 19 pneumonia -- lessions from the early outbreak.

Zhigang Wang1, Zhiqiang Wang2.   

Abstract

BACKGROUND: To examine the clinical characteristics and identify independent risk factors for in-hospital mortality of 2019 novel coronavirus (COVID-19) pneumonia.
METHODS: A total of 156 patients diagnosed with COVID-19 pneumonia at the Central Hospital of Wuhan from January 29, 2020, to March 20, 2020, and 20 healthy individuals were enrolled in this single-centered retrospective study. The epidemiological parameters, clinical presentations, underlying diseases, laboratory test results, and disease outcomes were collected and analyzed.
RESULTS: The median age of all enrolled patients was 66 years. At least one underlying disease was identified in 101 COVID-19 patients, with hypertension being the most common one, followed by cardiovascular disease and diabetes. The most common symptoms identified upon admission were fever, cough, dyspnea, and fatigue. Compared to survival cases, patients who died during hospitalization had higher plasma levels of D-dimer, creatinine, creatine kinase, lactate dehydrogenase, lactate, and lower percentage of lymphocytes (LYM [%]), platelet count and albumin levels. Most enrolled patients received antibiotics and anti-viral treatment. In addition, 60 patients received corticosteroids, and 51 received intravenous immunoglobulin infusion. Forty-four patients received noninvasive ventilation and 19 received invasive ventilation. Respiratory failure was the most frequently observed complication (106 [67.9%]), followed by sepsis (103 [66.0%]), acute respiratory distress syndrome (ARDS) (67 [42.9%]), and septic shock (50 [32.1%]). Multivariable regression suggested that advanced age (OR [odds ratio] = 1.098, 95% CI [confidence interval]: 1.006-1.199, P = 0.037), shorter duration from onset to admission (OR = 0.853, 95% CI: 0.750-0.969, P = 0.015) and elevated lactate level upon admission (OR = 2.689, 95% CI: 1.044-6.926, P = 0.040) were independent risk factors for in-hospital mortality for COVID-19 infection. Meanwhile, increased LYM (%) at admission (OR = 0.787, 95% CI: 0.686-0.903, P = 0.001) indicated a better prognosis.
CONCLUSIONS: In this study, we discovered that age, duration from onset to admission, LYM (%), and lactate level upon admission were independent factors that affecting the in-hospital mortality rate.

Entities:  

Keywords:  COVID-19; Characteristics; Risk factors; Survivors; Therapy

Mesh:

Substances:

Year:  2021        PMID: 33494706      PMCID: PMC7829622          DOI: 10.1186/s12879-021-05814-4

Source DB:  PubMed          Journal:  BMC Infect Dis        ISSN: 1471-2334            Impact factor:   3.090


  31 in total

Review 1.  Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).

Authors:  Manu Shankar-Hari; Gary S Phillips; Mitchell L Levy; Christopher W Seymour; Vincent X Liu; Clifford S Deutschman; Derek C Angus; Gordon D Rubenfeld; Mervyn Singer
Journal:  JAMA       Date:  2016-02-23       Impact factor: 56.272

2.  Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome.

Authors:  Yong Jiang; Jun Xu; Chengzhi Zhou; Zhenguo Wu; Shuqing Zhong; Jinghua Liu; Wei Luo; Tao Chen; Qinghe Qin; Peng Deng
Journal:  Am J Respir Crit Care Med       Date:  2005-01-18       Impact factor: 21.405

3.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.

Authors:  Dawei Wang; Bo Hu; Chang Hu; Fangfang Zhu; Xing Liu; Jing Zhang; Binbin Wang; Hui Xiang; Zhenshun Cheng; Yong Xiong; Yan Zhao; Yirong Li; Xinghuan Wang; Zhiyong Peng
Journal:  JAMA       Date:  2020-03-17       Impact factor: 56.272

4.  Risk factors for mortality in patients with low lactate level and septic shock.

Authors:  Dong Hyun Oh; Moo Hyun Kim; Woo Yong Jeong; Yong Chan Kim; Eun Jin Kim; Je Eun Song; In Young Jung; Su Jin Jeong; Nam Su Ku; Jun Yong Choi; Young Goo Song; June Myung Kim
Journal:  J Microbiol Immunol Infect       Date:  2017-08-26       Impact factor: 4.399

5.  Exacerbated innate host response to SARS-CoV in aged non-human primates.

Authors:  Saskia L Smits; Anna de Lang; Judith M A van den Brand; Lonneke M Leijten; Wilfred F van IJcken; Marinus J C Eijkemans; Geert van Amerongen; Thijs Kuiken; Arno C Andeweg; Albert D M E Osterhaus; Bart L Haagmans
Journal:  PLoS Pathog       Date:  2010-02-05       Impact factor: 6.823

6.  Relationship between Central and Peripheral Venous Oxygen Saturation and Lactate Levels: A Prospective Study.

Authors:  Nikhil Goyal; Andrew R Taylor; Emanuel P Rivers
Journal:  J Emerg Med       Date:  2016-05-19       Impact factor: 1.484

7.  A novel coronavirus outbreak of global health concern.

Authors:  Chen Wang; Peter W Horby; Frederick G Hayden; George F Gao
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

Review 8.  Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China.

Authors:  Bo Li; Jing Yang; Faming Zhao; Lili Zhi; Xiqian Wang; Lin Liu; Zhaohui Bi; Yunhe Zhao
Journal:  Clin Res Cardiol       Date:  2020-03-11       Impact factor: 6.138

9.  The risk factors associated with MERS-CoV patient fatality: A global survey.

Authors:  Jamal Ahmadzadeh; Kazhal Mobaraki; Seyed Jalil Mousavi; Javad Aghazadeh-Attari; Mohammad Mirza-Aghazadeh-Attari; Iraj Mohebbi
Journal:  Diagn Microbiol Infect Dis       Date:  2019-07-31       Impact factor: 2.803

10.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.

Authors:  Fei Zhou; Ting Yu; Ronghui Du; Guohui Fan; Ying Liu; Zhibo Liu; Jie Xiang; Yeming Wang; Bin Song; Xiaoying Gu; Lulu Guan; Yuan Wei; Hui Li; Xudong Wu; Jiuyang Xu; Shengjin Tu; Yi Zhang; Hua Chen; Bin Cao
Journal:  Lancet       Date:  2020-03-11       Impact factor: 79.321

View more
  11 in total

1.  Barthel's Index: A Better Predictor for COVID-19 Mortality Than Comorbidities.

Authors:  João Cordeiro da Costa; Maria Conceição Manso; Susana Gregório; Márcia Leite; João Moreira Pinto
Journal:  Tuberc Respir Dis (Seoul)       Date:  2022-06-23

2.  A new screening tool for SARS-CoV-2 infection based on self-reported patient clinical characteristics: the COV19-ID score.

Authors:  Pablo Diaz Badial; Hugo Bothorel; Omar Kherad; Philippe Dussoix; Faustine Tallonneau Bory; Majd Ramlawi
Journal:  BMC Infect Dis       Date:  2022-02-24       Impact factor: 3.090

3.  Clinical Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP).

Authors:  Matteo Bassetti; Daniele Roberto Giacobbe; Paolo Bruzzi; Emanuela Barisione; Stefano Centanni; Nadia Castaldo; Silvia Corcione; Francesco Giuseppe De Rosa; Fabiano Di Marco; Andrea Gori; Andrea Gramegna; Guido Granata; Angelo Gratarola; Alberto Enrico Maraolo; Malgorzata Mikulska; Andrea Lombardi; Federico Pea; Nicola Petrosillo; Dejan Radovanovic; Pierachille Santus; Alessio Signori; Emanuela Sozio; Elena Tagliabue; Carlo Tascini; Carlo Vancheri; Antonio Vena; Pierluigi Viale; Francesco Blasi
Journal:  Infect Dis Ther       Date:  2021-07-30

4.  Role of non-thyroidal illness syndrome in predicting adverse outcomes in COVID-19 patients predominantly of mild-to-moderate severity.

Authors:  David Tak Wai Lui; Chi Ho Lee; Wing Sun Chow; Alan Chun Hong Lee; Anthony Raymond Tam; Carol Ho Yi Fong; Chun Yiu Law; Eunice Ka Hong Leung; Kelvin Kai Wang To; Kathryn Choon Beng Tan; Yu Cho Woo; Ching Wan Lam; Ivan Fan Ngai Hung; Karen Siu Ling Lam
Journal:  Clin Endocrinol (Oxf)       Date:  2021-04-12       Impact factor: 3.523

5.  Cardiovascular risk factors and clinical outcomes of patients hospitalized with COVID-19 pneumonia in Somalia.

Authors:  Mohammed A M Ahmed; Ahmed Mohamud Hussein; Aweis Ahmed Moalim Abdullahi; Abdirizak Yusuf Ahmed; Hamdi M A Hussain; Abdiaziz Mohamed Ali; Abdulqadir Abdinur Barre; Farhia Mohamud Yusuf; Ronald Olum; Senai Goitom Sereke; Maisa Ahmed Elfadul; Robert Colebunders; Felix Bongomin
Journal:  Ther Adv Infect Dis       Date:  2022-04-25

6.  Determinants of severity among hospitalised COVID-19 patients: Hospital-based case-control study, India, 2020.

Authors:  Sanjay P Zodpey; Himanshu Negandhi; Vineet Kumar Kamal; Tarun Bhatnagar; Parasuraman Ganeshkumar; Arvind Athavale; Amiruddin Kadri; Amit Patel; A Bhagyalaxmi; Deepak Khismatrao; E Theranirajan; Getrude Banumathi; Krishna Singh; P Parameshwari; Prasita Kshirsagar; Rita Saxena; Sanjay G Deshpande; Kadloor Satyanand; Saurabh Hadke; Simmi Dube; Sudarshini Subramaniam; Surabhi Madan; Swapnali Kadam; Tanu Anand; Kathiresan Jeyashree; Manickam Ponnaiah; Manish Rana; Manoj V Murhekar; Dcs Reddy
Journal:  PLoS One       Date:  2021-12-29       Impact factor: 3.240

Review 7.  Serum CK-MB, COVID-19 severity and mortality: An updated systematic review and meta-analysis with meta-regression.

Authors:  Angelo Zinellu; Salvatore Sotgia; Alessandro G Fois; Arduino A Mangoni
Journal:  Adv Med Sci       Date:  2021-07-07       Impact factor: 3.287

Review 8.  Identification of Parameters Representative of Immune Dysfunction in Patients with Severe and Fatal COVID-19 Infection: a Systematic Review and Meta-analysis.

Authors:  Rundong Qin; Li He; Zhaowei Yang; Nan Jia; Ruchong Chen; Jiaxing Xie; Wanyi Fu; Hao Chen; Xinliu Lin; Renbin Huang; Tian Luo; Yukai Liu; Siyang Yao; Mei Jiang; Jing Li
Journal:  Clin Rev Allergy Immunol       Date:  2022-01-18       Impact factor: 10.817

9.  The Effectiveness of the Use of Regdanvimab (CT-P59) in Addition to Remdesivir in Patients with Severe COVID-19: A Single Center Retrospective Study.

Authors:  Ganghee Chae; Aram Choi; Soyeoun Lim; Sooneun Park; Seungjun Lee; Youngick Ahn; Jinhyoung Kim; Seungwon Ra; Yangjin Jegal; Jongjoon Ahn; Eunji Park; Jaebum Jun; Woonjung Kwon; Taehoon Lee
Journal:  Trop Med Infect Dis       Date:  2022-03-18

10.  Air leak with COVID-19 - A meta-summary.

Authors:  Prashant Nasa; Deven Juneja; Ravi Jain
Journal:  Asian Cardiovasc Thorac Ann       Date:  2021-07-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.